Increase in Workplace Injuries Among Young Workers Following the Legalization of Recreational Marijuana Sales, Reports Drugs.com MedNews

Title: Rise in Workplace Injuries Among Young Workers After Legalizing Recreational Marijuana Sales Introduction The legalization of recreational marijuana sales...

Understanding the Right Drug Choice: A Comparison of ANDA and 505(b)(2) in BioPharma Services In the world of pharmaceuticals, the...

Ocugen, a biopharmaceutical company focused on developing gene therapies to treat rare eye diseases, has recently announced the successful completion...

Introducing ClinEco Commons: A Comprehensive Portal for Industry Resources and Expertise In today’s rapidly evolving healthcare industry, staying up-to-date with...

Clinical trials play a crucial role in advancing medical knowledge and improving patient care. They are essential for testing new...

Insights on SCOPE 2024: YPrime CEO, Jim Corrigan Discusses Company Progress and Tackling Uncertainty in Clinical Trials The clinical trial...

The Inflation Reduction Act for Clinical Research Professionals (ACRP) is a significant piece of legislation that aims to address the...

The Food and Drug Administration (FDA) has recently approved the expanded use of Xolair, a medication primarily used for treating...

Title: Nearly 15% of Americans Deny Climate Change, Contrary to Evidence Introduction Climate change is a pressing global issue that...

Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...

The Impact of 30 Years of QPS on Clinical Research: A Comprehensive Exploration Over the past three decades, Quality Patient...

FDA Endorses Tricuspid Regurgitation Device Following Positive Findings in TRILUMINATE Clinical Trial Tricuspid regurgitation (TR) is a condition where the...

Title: Oregon Man Likely Contracted Bubonic Plague from Pet Cat, According to Drugs.com MedNews Introduction In a startling revelation, an...

Phase IIb trial results have recently revealed that Tozorakimab, a potential treatment for diabetic kidney disease (DKD), did not meet...

An In-depth Analysis of the Expensive Drug Development Process The process of developing new drugs is a complex and expensive...

Understanding the Impact of the Winds of Change Change is an inevitable part of life. Just like the wind, it...

Understanding and Preventing Winter Migraines in Seattle: Insights from Seattle Clinical Research Center Winter can be a beautiful time in...

The Super Bowl is one of the most anticipated sporting events of the year, bringing together friends and family to...

Decrease in Invasive Meningitis Cases Observed after Vaccine Introduction in Western Australia Meningitis is a serious and potentially life-threatening infection...

Drugs.com MedNews Reports on a Groundbreaking Prosthetic Hand with Temperature Sensing Abilities In recent years, advancements in prosthetic technology have...

Understanding the Site Perspective on eCOA Flexibility in Clinical Trials Electronic Clinical Outcome Assessments (eCOA) have become increasingly popular in...

Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...

An Informative Overview of 15 Different Aspects of Change in Clinical Trial Start-Up and Execution Clinical trials play a crucial...

Title: Alarming Rise in Global Shark Bites: A Closer Look at the Facts Introduction: Shark bites have long been a...

Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...

Bunions are a common foot condition that can cause pain and discomfort. They occur when the joint at the base...

As the winter season approaches, it becomes even more crucial to take care of our immune system. The cold weather,...

Title: The Rapid Impact of Switching to Vegan or Ketogenic Diet on the Immune System Introduction: Diet plays a crucial...

The Efficiency of Machine Learning in Organizing Patient Safety Event Reports Patient safety is a critical aspect of healthcare, and...

FDA Expedites Development of RNA Exon Editor for Stargardt Disease in Clinical Trials Stargardt disease, also known as Stargardt macular...

Noah’s Wholesale, LLC Voluntarily Recalls the Rock Nationwide Due to Undeclared Sildenafil

Noah’s Wholesale, LLC Voluntarily Recalls the Rock Nationwide Due to Undeclared Sildenafil

Noah’s Wholesale, LLC, a leading distributor of dietary supplements, has issued a voluntary recall of its popular product, “The Rock,” due to the presence of undeclared sildenafil. The recall comes after an FDA analysis found that the product contained sildenafil, which is an active ingredient in FDA-approved prescription drugs used to treat erectile dysfunction.

Sildenafil is a potent drug that can interact with nitrates found in some prescription drugs, such as nitroglycerin, and can lower blood pressure to dangerous levels. This poses a significant risk for consumers with underlying medical conditions, such as diabetes, high blood pressure, or heart disease.

“The Rock” is marketed as a dietary supplement for male sexual enhancement and is sold nationwide through various retail stores and online platforms. The product is packaged in blister packs containing one pill per pack.

Consumers who have purchased “The Rock” are urged to stop using it immediately and return it to the place of purchase for a full refund. Retailers and distributors are also advised to remove the product from their shelves and contact Noah’s Wholesale, LLC for further instructions on returning the product.

Noah’s Wholesale, LLC is working closely with the FDA to investigate the source of the undeclared sildenafil and to ensure that all necessary steps are taken to prevent future occurrences. The company is committed to the safety and well-being of its customers and takes this matter seriously.

The FDA is also urging consumers who have experienced any adverse reactions or problems related to the use of “The Rock” to report it through the FDA’s MedWatch Adverse Event Reporting program. This will help the FDA gather more information about potential risks associated with the product and take appropriate actions to protect public health.

It is important for consumers to be aware of the potential risks associated with dietary supplements, as they are not subject to the same rigorous testing and regulations as prescription drugs. The FDA recommends that consumers consult with their healthcare providers before using any dietary supplements, especially if they have underlying medical conditions or are taking other medications.

This recall serves as a reminder for both consumers and manufacturers to be vigilant about the safety of dietary supplements. Manufacturers should ensure that their products are accurately labeled and free from undeclared ingredients, while consumers should exercise caution and do their research before using any dietary supplement.

In conclusion, Noah’s Wholesale, LLC has voluntarily recalled “The Rock” due to the presence of undeclared sildenafil. Consumers are advised to stop using the product immediately and return it for a refund. The FDA is actively investigating the matter and encourages consumers to report any adverse reactions. This recall highlights the importance of ensuring the safety of dietary supplements and the need for consumer awareness when using such products.

Ai Powered Web3 Intelligence Across 32 Languages.